Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel antihyperlipidemic agent from Shionogi in phase II

March 20, 1997

Wyeth-Ayerst acquires commercialization rights to rhIL-11

March 19, 1997

Cabergoline launched in U.S.

March 19, 1997

Preliminary clinical results with CI-1000

March 18, 1997

Pharmacokinetics of paracalcin in patients undergoing hemodialysis

March 18, 1997

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

March 17, 1997

Genzyme Transgenics and Fresenius to further development of transgenic albumin

March 17, 1997

MGI Pharma and Schein reach marketing agreement for INFeD

March 14, 1997

MP-52 enters clinic

March 14, 1997

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Menstrual ‘footprints’ may act as broad personal health markers
BioWorld
WAVES, an algorithm designed to extract menstrual-cycle metrics from physiological signals such as basal body temperature, which oscillates with sex hormones,...